# Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/azacitidine-for-treatment-of-imminent-relapse-in-mds-or-aml-patients-after/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Uwe Platzbecker,Martin Wermke,J. Radke,Uta Oelschlaegel,Franzi Seltmann,Alexander Kiani,I-M Klut,Holger Knoth,Christoph Röllig,Johannes Schetelig,Brigitte Mohr,Xina Graehlert,Gerhard Ehninger,Martin Bornhäuser,Christian Thiede |
| Citations | 397 |
| DOI | 10.1038/leu.2011.234 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/leu2011234.pdf |
| OpenAlex ID | https://openalex.org/W2021378114 |
| PMID | 21886171 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Martin Wermke](https://scholariq.org/researchers/martin-wermke/)

## Paper primary topic

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Paper topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.